|
1
|
Liu S, Chen Q, Guo L, Cao X, Sun X, Chen W
and He J: Incidence and mortality of lung cancer in China,
2008–2012. Chin J Cancer Res. 30:580–587. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Travis WD; World Health Organization,
International Agency for Research on Cancer, ; et al: Pathology and
genetics of tumours of the lung, pleura, thymus and heart. Tumours
of lung. Lyon, IARC Press. (France). 26–67. 2003.
|
|
3
|
Sanders HR and Albitar M: Somatic
mutations of signaling genes in non-small-cell lung cancer. Cancer
Genet Cytogenet. 203:7–15. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Spira A and Ettinger DS: Multidisciplinary
management of lung cancer. N Engl J Med. 360:19172009. View Article : Google Scholar
|
|
5
|
Jiang F, Qiu Q, Khanna A, Todd NW, Deepak
J, Xing L, Wang H, Liu Z, Su Y, Stass SA, et al: Aldehyde
dehydrogenase 1 is a tumor stem cell-associated marker in lung
cancer. Mol Cancer Res. 7:330–338. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Eramo A, Lotti F, Sette G, Pilozzi E,
Biffoni M, Di Virgilio A, Conticello C, Ruco L, Peschle C and De
Maria R: Identification and expansion of the tumorigenic lung
cancer stem cell population. Cell Death Differ. 15:504–514. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cao X, Zou H, Cao J, Cui Y, Sun S, Ren K,
Song Z, Li D and Quan M: A candidate Chinese medicine
preparation-Fructus Viticis Total Flavonoids inhibits stem-like
characteristics of lung cancer stem-like cells. BMC Complement
Altern Med. 16:3642016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Codony-Servat J, Verlicchi A and Rosell R:
Cancer stem cells in small cell lung cancer. Transl Lung Cancer
Res. 5:16–25. 2016.PubMed/NCBI
|
|
9
|
Hart PC, Mao M, de Abreu AL,
Ansenberger-Fricano K, Ekoue DN, Ganini D, Kajdacsy-Balla A,
Diamond AM, Minshall RD, Consolaro ME, et al: MnSOD upregulation
sustains the Warburg effect via mitochondrial ROS and
AMPK-dependent signalling in cancer. Nat Commun. 6:60532015.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen PM, Cheng YW, Wu TC, Chen CY and Lee
H: MnSOD overexpression confers cisplatin resistance in lung
adenocarcinoma via the NF-κB/Snail/Bcl-2 pathway. Free Radic Biol
Med. 79:127–137. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ito H, Matsui H, Hirayama A, Indo HP,
Majima HJ and Hyodo I: Reactive oxygen species induced by
non-steroidal anti-inflammatory drugs enhance the effects of
photodynamic therapy in gastric cancer cells. J Clin Biochem Nutr.
58:180–185. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xing ZG, Yu GD, Qin L, Jiang F and Zhao
WH: Effects and mechanism of lipoic acid on
beta-amyloid-intoxicated C6 glioma cells. Genet Mol Res.
14:13880–13888. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang W, Jia HL, Huang JM, Liang YC, Tan H,
Geng HZ, Guo LY and Yao SZ: Identification of biomarkers for lymph
node metastasis in early-stage cervical cancer by tissue-based
proteomics. Br J Cancer. 110:1748–1758. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Church SL, Grant JW, Ridnour LA, Oberley
LW, Swanson PE, Meltzer PS and Trent JM: Increased manganese
superoxide dismutase expression suppresses the malignant phenotype
of human melanoma cells. Proc Natl Acad Sci USA. 90:3113–3117.
1993. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ough M, Lewis A, Zhang Y, Hinkhouse MM,
Ritchie JM, Oberley LW and Cullen JJ: Inhibition of cell growth by
overexpression of manganese superoxide dismutase (MnSOD) in human
pancreatic carcinoma. Free Radical Res. 38:1223–1233. 2004.
View Article : Google Scholar
|
|
16
|
Behrend L, Mohr A, Dick T and Zwacka RM:
Manganese superoxide dismutase induces p53-dependent senescence in
colorectal cancer cells. Mol Cell Biol. 25:7758–7769. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fu Z, Cao X, Yang Y, Song Z, Zhang J and
Wang Z: Upregulation of FoxM1 by MnSOD overexpression contributes
to cancer stem-like cell characteristics in the lung cancer H460
cell line. Technol Cancer Res Treat. 17:15330338187896352018.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Myatt SS and Lam EW: The emerging roles of
forkhead box (Fox) proteins in cancer. Nat Rev Cancer. 7:847–859.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang Z, Ahmad A, Li Y, Banerjee S, Kong D
and Sarkar FH: Forkhead box M1 transcription factor: A novel target
for cancer therapy. Cancer Treat Rev. 36:151–156. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Priller M, Poschl J, Abrao L, von Bueren
AO, Cho YJ, Rutkowski S, Kretzschmar HA and Schuller U: Expression
of FoxM1 is required for the proliferation of medulloblastoma cells
and indicates worse survival of patients. Clin Cancer Res.
17:6791–6801. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Anders L, Ke N, Hydbring P, Choi YJ,
Widlund HR, Chick JM, Zhai H, Vidal M, Gygi SP, Braun P and
Sicinski P: A systematic screen for CDK4/6 substrates links FOXM1
phosphorylation to senescence suppression in cancer cells. Cancer
Cell. 20:620–634. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kong X, Li L, Li Z, Le X, Huang C, Jia Z,
Cui J, Huang S, Wang L and Xie K: Dysregulated expression of FOXM1
isoforms drives progression of pancreatic cancer. Cancer Res.
73:3987–3996. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li D, Wei P, Peng Z, Huang C, Tang H, Jia
Z, Cui J, Le X, Huang S and Xie K: The critical role of
dysregulated FOXM1-PLAUR signaling in human colon cancer
progression and metastasis. Clin Cancer Res. 19:62–72. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yazdani Y, Sharifi Rad MR, Taghipour M,
Chenari N, Ghaderi A and Razmkhah M: Genistein suppression of
matrix metalloproteinase 2 (MMP-2) and Vascular Endothelial Growth
Factor (VEGF) expression in mesenchymal stem cell like cells
isolated from high and low grade gliomas. Asian Pac J Cancer Prev.
17:5303–5307. 2016.PubMed/NCBI
|
|
25
|
Engel N, Adamus A, Schauer N, Kuhn J, Nebe
B, Seitz G and Kraft K: Synergistic action of genistein and
calcitriol in immature osteosarcoma MG-63 cells by SGPL1
Up-regulation. PLoS One. 12:e01697422017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Antosiak A, Milowska K, Maczynska K,
Rozalska S and Gabryelak T: Cytotoxic activity of
genistein-8-C-glucoside form Lupinus luteus L. and genistein
against human SK-OV-3 ovarian carcinoma cell line. Med Chem Res.
26:64–73. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
El-Rayes BF, Ali S, Ali IF, Philip PA,
Abbruzzese J and Sarkar FH: Potentiation of the effect of erlotinib
by genistein in pancreatic cancer: The role of Akt and nuclear
factor-kappaB. Cancer Res. 66:10553–10559. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ning Y, Luo C, Ren K, Quan M and Cao J:
FOXO3a-mediated suppression of the self-renewal capacity of
sphere-forming cells derived from the ovarian cancer SKOV3 cell
line by 7-difluoromethoxyl-5,4′-di-n-octyl genistein. Mol Med Rep.
9:1982–1988. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ning YX, Li QX, Ren KQ, Quan MF and Cao
JG: 7-difluoromethoxyl-5,4′-di-n-octyl genistein inhibits ovarian
cancer stem cell characteristics through the downregulation of FO
XM1. Oncol Lett. 8:295–300. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhu J, Ren J and Tang L: Genistein
inhibits invasion and migration of colon cancer cells by recovering
WIF1 expression. Mol Med Rep. 17:7265–7273. 2018.PubMed/NCBI
|
|
31
|
Chan KKL, Siu MKY, Jiang YX, Wang JJ,
Leung THY and Ngan HYS: Estrogen receptor modulators genistein,
daidzein and ERB-041 inhibit cell migration, invasion,
proliferation and sphere formation via modulation of FAK and
PI3K/AKT signaling in ovarian cancer. Cancer Cell Int. 18:652018.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hussain A, Harish G, Prabhu SA, Mohsin J,
Khan MA, Rizvi TA and Sharma C: Inhibitory effect of genistein on
the invasive potential of human cervical cancer cells via
modulation of matrix metalloproteinase-9 and tissue inhibitors of
matrix metalloproteinase-1 expression. Cancer Epidemiol.
36:e387–e393. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Cui S, Wang J, Wu Q, Qian J, Yang C and Bo
P: Genistein inhibits the growth and regulates the migration and
invasion abilities of melanoma cells via the FAK/paxillin and MAPK
pathways. Oncotarget. 8:21674–21691. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Cao X, Liu L, Yuan Q, Li X, Cui Y, Ren K,
Zou C, Chen A, Xu C, Qiu Y, et al: Isovitexin reduces
carcinogenicity and stemness in hepatic carcinoma stem-like cells
by modulating MnSOD and FoxM1. J Exp Clin Cancer Res. 38:2642019.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Luo Y, Cui Y, Cao X, Li X, Chen A, Zhang
J, Chen X and Cao J: 8-Bromo-7-methoxychrysin-blocked STAT3/Twist
axis inhibits the stemness of cancer stem cell-like cell originated
from SMMC-7721 cells. Acta Biochim Biophys Sin (Shanghai).
49:458–64. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Bao B, Wang Z, Ali S, Kong D, Banerjee S,
Ahmad A, Li Y, Azmi AS, Miele L and Sarkar FH: Over-expression of
FoxM1 leads to epithelial-mesenchymal transition and cancer stem
cell phenotype in pancreatic cancer cells. J Cell Biochem.
112:2296–2306. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Huang W, Wan C and Luo Q, Huang Z and Luo
Q: Genistein-inhibited cancer stem cell-like properties and reduced
chemoresistance of gastric cancer. Int J Mol Sci. 15:3432–443.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Fan P, Fan S, Wang H, Mao J, Shi Y,
Ibrahim MM, Ma W, Yu X, Hou Z, Wang B, et al: Genistein decreases
the breast cancer stem-like cell population through Hedgehog
pathway. Stem Cell Res Ther. 4:1462013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Luo Y, Wang SX, Zhou ZQ, Wang Z, Zhang YG,
Zhang Y and Zhao P: Apoptotic effect of genistein on human colon
cancer cells via inhibiting the nuclear factor-kappa B (NF-kappaB)
pathway. Tumour Biol. 35:11483–11488. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kopanja D, Pandey A, Kiefer M, Wang Z,
Chandan N, Carr JR, Franks R, Yu DY, Guzman G, Maker A, et al:
Essential roles of FoxM1 in Ras-induced liver cancer progression
and in cancer cells with stem cell features. J Hepatol. 63:429–436.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zhang J, Zhang J, Cui X, Yang Y, Li M, Qu
J, Li J and Wang J: FoxM1: A novel tumor biomarker of lung cancer.
Int J Clin Exp Med. 8:3136–3140. 2015.PubMed/NCBI
|
|
42
|
Tian T, Li J, Li B, Wang Y, Li M, Ma D and
Wang X: Genistein exhibits anti-cancer effects via down-regulating
FoxM1 in H446 small-cell lung cancer cells. Tumour Biol.
35:4137–4145. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Prietsch RF, Monte LG, da Silva FA, Beira
FT, Del Pino FA, Campos VF, Collares T, Pinto LS, Spanevello RM,
Gamaro GD, et al: Genistein induces apoptosis and autophagy in
human breast MCF-7 cells by modulating the expression of
proapoptotic factors and oxidative stress enzymes. Mol Cell
Biochem. 390:235–242. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Ning Y, Li Q, Xiang H, Liu F and Cao J:
Apoptosis induced by 7-difluoromethoxyl-5,4′-di-n-octyl genistein
via the inactivation of FoxM1 in ovarian cancer cells. Oncol Rep.
27:1857–1864. 2012.PubMed/NCBI
|
|
45
|
Xiang HL, Liu F, Quan MF, Cao JG and Lv Y:
7-difluoromethoxyl-5,4′-di-n-octylgenistein inhibits growth of
gastric cancer cells through downregulating forkhead box M1. World
J Gastroenterol. 18:4618–4626. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Cao X, Ren K, Song Z, Li D, Quan M, Zheng
Y, Cao J, Zeng W and Zou H: 7-Difluoromethoxyl-5,4′-di-n-octyl
genistein inhibits the stem-like characteristics of gastric cancer
stem-like cells and reverses the phenotype of
epithelial-mesenchymal transition in gastric cancer cells. Oncol
Rep. 36:1157–1165. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Su J, Wu S, Wu H, Li L and Guo T: CD44 is
functionally crucial for driving lung cancer stem cells metastasis
through Wnt/β-catenin-FoxM1-Twist signaling. Mol Carcinog.
55:1962–1973. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Su YJ, Lin WH, Chang YW, Wei KC, Liang CL,
Chen SC and Lee JL: Polarized cell migration induces cancer
type-specific CD133/integrin/Src/Akt/GSK3β/β-catenin signaling
required for maintenance of cancer stem cell properties.
Oncotarget. 6:38029–38045. 2015. View Article : Google Scholar : PubMed/NCBI
|
